4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives $47.14 Consensus Target Price from Brokerages
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) have been given an average rating of “Moderate Buy” ...